“…Alternatively, GM-CSF may enhance the expression of class I HLA antigens directly or indirectly, possibly via activation of the cytokine network. In vitro, the recombinant cytokines IL-1, IL-2, interferon-alpha, interferon-gamma and tumour necrosis factor have been observed to enhance the production of b 2 m of both normal and leukaemic B cells ( Jones et al, 1990). In multiple myeloma and chronic myeloproliferative diseases, administration of interferon-alpha at clinical doses has been shown to cause a rapid increase in serum b 2 m concentration (Remes et al, 1993).…”